ZWJ Investment Counsel’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $46.3M | Buy |
92,414
+4,559
| +5% | +$2.19M | 1.5% | 24 |
|
|
2026
Q1 | $43.2M | Buy |
87,855
+2,326
| +3% | +$1.26M | 1.56% | 28 |
|
|
2025
Q4 | $49.6M | Buy |
85,529
+1,850
| +2% | +$1.05M | 1.79% | 20 |
|
|
2025
Q3 | $40.6M | Buy |
83,679
+1,131
| +1% | +$526K | 1.43% | 27 |
|
|
2025
Q2 | $33.5M | Buy |
82,548
+4,778
| +6% | +$2M | 1.24% | 31 |
|
|
2025
Q1 | $38.7M | Buy |
77,770
+2,618
| +3% | +$1.42M | 1.57% | 27 |
|
|
2024
Q4 | $39.1M | Buy |
75,152
+1,897
| +3% | +$1.04M | 1.62% | 25 |
|
|
2024
Q3 | $45.3M | Buy |
73,255
+938
| +1% | +$555K | 1.85% | 23 |
|
|
2024
Q2 | $40M | Buy |
72,317
+2,714
| +4% | +$1.55M | 1.76% | 25 |
|
|
2024
Q1 | $40.5M | Buy |
69,603
+778
| +1% | +$437K | 1.84% | 26 |
|
|
2023
Q4 | $36.5M | Sell |
68,825
-425
| -0.6% | -$206K | 1.88% | 22 |
|
|
2023
Q3 | $35.1M | Buy |
69,250
+168
| +0.2% | +$89.5K | 1.94% | 21 |
|
|
2023
Q2 | $36M | Buy |
69,082
+7,367
| +12% | +$3.98M | 1.88% | 22 |
|
|
2023
Q1 | $35.6M | Buy |
61,715
+1,762
| +3% | +$993K | 1.96% | 21 |
|
|
2022
Q4 | $33M | Buy |
59,953
+1,440
| +2% | +$763K | 1.87% | 23 |
|
|
2022
Q3 | $29.7M | Buy |
58,513
+219
| +0.4% | +$123K | 1.87% | 20 |
|
|
2022
Q2 | $31.7M | Buy |
58,294
+1,335
| +2% | +$735K | 1.85% | 18 |
|
|
2022
Q1 | $33.6M | Sell |
56,959
-209
| -0.4% | -$120K | 1.78% | 23 |
|
|
2021
Q4 | $38.1M | Sell |
57,168
-1,872
| -3% | -$1.17M | 1.95% | 15 |
|
|
2021
Q3 | $33.7M | Sell |
59,040
-4,910
| -8% | -$2.69M | 1.91% | 16 |
|
|
2021
Q2 | $32.3M | Sell |
63,950
-1,639
| -2% | -$773K | 1.87% | 18 |
|
|
2021
Q1 | $29.9M | Sell |
65,589
-8,451
| -11% | -$4.03M | 1.84% | 19 |
|
|
2020
Q4 | $34.5M | Buy |
74,040
+78
| +0.1% | +$36.6K | 2.34% | 12 |
|
|
2020
Q3 | $32.7M | Sell |
73,962
-2,138
| -3% | -$883K | 2.62% | 10 |
|
|
2020
Q2 | $27.6M | Buy |
76,100
+3,003
| +4% | +$1.01M | 2.39% | 12 |
|
|
2020
Q1 | $20.7M | Buy |
73,097
+5,053
| +7% | +$1.59M | 1.85% | 19 |
|
|
2019
Q4 | $22.1M | Sell |
68,044
-4,723
| -6% | -$1.43M | 1.49% | 27 |
|
|
2019
Q3 | $21.2M | Buy |
72,767
+3,016
| +4% | +$864K | 1.65% | 27 |
|
|
2019
Q2 | $20.5M | Buy |
69,751
+1,107
| +2% | +$305K | 1.61% | 27 |
|
|
2019
Q1 | $18.8M | Sell |
68,644
-97
| -0.1% | -$24.1K | 1.55% | 29 |
|
|
2018
Q4 | $15.4M | Buy |
68,741
+301
| +0.4% | +$70.6K | 1.45% | 30 |
|
|
2018
Q3 | $16.7M | Buy |
68,440
+635
| +0.9% | +$146K | 1.36% | 33 |
|
|
2018
Q2 | $14M | Buy |
67,805
+1,543
| +2% | +$328K | 1.21% | 39 |
|
|
2018
Q1 | $13.7M | Sell |
66,262
-2,629
| -4% | -$552K | 1.23% | 38 |
|
|
2017
Q4 | $13.1M | Buy |
68,891
+4,199
| +6% | +$804K | 1.03% | 37 |
|
|
2017
Q3 | $12.2M | Buy |
64,692
+1,464
| +2% | +$265K | 0.95% | 42 |
|
|
2017
Q2 | $11M | Buy |
63,228
+16,148
| +34% | +$2.71M | 0.88% | 44 |
|
|
2017
Q1 | $7.23M | Buy |
+47,080
| New | +$7.2M | 0.59% | 48 |
|
|
2014
Q3 | – | Sell |
-1,840
| Closed | -$217K | – | 139 |
|
|
2014
Q2 | $217K | Sell |
1,840
-630
| -26% | -$74.1K | 0.02% | 131 |
|
|
2014
Q1 | $297K | Sell |
2,470
-122,208
| -98% | -$14.5M | 0.03% | 120 |
|
|
2013
Q4 | $13.9M | Sell |
124,678
-4,001
| -3% | -$398K | 1.6% | 25 |
|
|
2013
Q3 | $11.9M | Sell |
128,679
-21,294
| -14% | -$1.93M | 1.52% | 29 |
|
|
2013
Q2 | $12.7M | Buy |
+149,973
| New | +$12.5M | 1.71% | 21 |
|
Other funds holding TMO
RG
ECSS
LT
ZWJ Investment Counsel's TMO Position: Q2 2026 in Review
ZWJ Investment Counsel increased its Thermo Fisher Scientific (TMO) stake by 5.2% in Q2 2026, buying an estimated $2.19M and bringing the position to 92,414 shares worth $46.3M. The position accounts for 1.5% of the portfolio, ranked #24.
ZWJ Investment Counsel first reported a position in TMO in Q2 2013 and has held it in 43 quarters since. The position peaked at $49.6M in Q4 2025. 1,085 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- ZWJ Investment Counsel held 92,414 shares of Thermo Fisher Scientific worth $46.3M as of Q2 2026.
- ZWJ Investment Counsel bought 4,559 Thermo Fisher Scientific shares in Q2 2026, an estimated $2.19M.
- Thermo Fisher Scientific made up 1.5% of ZWJ Investment Counsel's portfolio in Q2 2026, its #24 holding.
- ZWJ Investment Counsel first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 43 quarters since.
- ZWJ Investment Counsel's Thermo Fisher Scientific position peaked at $49.6M in Q4 2025.
- 1,085 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on ZWJ Investment Counsel's 13F filing for Q2 2026, filed 16 Jul 2026.